Residency · Syracuse, NY
Sponsored by SUNY Upstate Medical University
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 1,863 citations · Aung Naing
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.
International journal of molecular sciences · 2022 · 1,007 citations · Maroun Zerdan
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial.
Lancet (London, England) · 2025 · 317 citations · Hatim Karachiwala
Cancer treatments: Past, present, and future.
Cancer genetics · 2024 · 490 citations · Anish Thomas
Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes.
Nature · 2023 · 372 citations · Laura Pardilla
5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
Journal of the American College of Cardiology · 2025 · 103 citations · Ayman Iskander
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
The New England journal of medicine · 2022 · 422 citations · Teresa Gentile, Pallawi Torka
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials.
Nature medicine · 2023 · 334 citations · Aung Naing